表紙
市場調查報告書
商品編碼
1082810

微創青光眼手術用設備的全球市場:2022年∼2029年

Global Minimally Invasive Glaucoma Surgery Devices Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球微創青光眼手術用設備的市場調查,彙整市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素的分析,法律制度,市場規模的轉變·預測,各種區分·地區/各主要國家的明細,競爭環境,主要企業簡介等資訊。

目錄

第1章 全球微創青光眼手術用設備市場:調查手法·調查範圍

第2章 全球微創青光眼手術用設備市場:市場定義和概要

第3章 全球微創青光眼手術用設備市場:摘要整理

第4章 全球微創青光眼手術用設備市場:市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球微創青光眼手術用設備市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 法規分析

第6章 全球微創青光眼手術用設備市場:COVID-19分析

  • COVID-19:對市場的影響分析
  • COVID-19風暴中的價格動態
  • 供需頻譜
  • 政府在COVID-19疫情下的市場相關措施
  • 製造商的策略性舉措
  • 總論

第7章 全球微創青光眼手術用設備市場:各產品

  • 微創青光眼手術用支架
  • 微創青光眼手術用分流術
  • 其他

第8章 全球微創青光眼手術用設備市場:各類型

  • 小柱
  • 脈絡薄膜
  • 結膜下

第9章 全球微創青光眼手術用設備市場:各手術類型

  • 伴隨白內障的青光眼
  • 只青光眼

第10章 全球微創青光眼手術用設備市場:各終端用戶

  • 眼科醫院
  • 門診病人手術中心
  • 眼科診所
  • 其他

第11章 全球微創青光眼手術用設備市場:各地區

  • 北美
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第12章 全球微創青光眼手術用設備市場:競爭情形

  • 主要的展開·策略
  • 企業佔有率分析
  • 產品基準

第13章 全球微創青光眼手術用設備市場:企業簡介

  • Ivantis Inc
  • Glaukos Corporation
  • Lumenis Ltd
  • Novartis
  • Ellex Medical Lasers
  • BVI
  • ASICO
  • Allcon
  • Katalystsurgical
  • IOPtima

第14章 全球微創青光眼手術用設備市場:DataM

目錄
Product Code: DMMD5232

Market Overview

The global minimally invasive glaucoma surgery devices market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

For the treatment of glaucoma patients, minimally invasive glaucoma surgery devices provide an ab interno technique that avoids medication and conjunctival invasion. Minimally Invasive Glaucoma Surgery devices, such as stents, shunts, and micro-implants, treat individuals with mild-to-moderate glaucoma.

Market Dynamics

Over the years, there has been an increase in the preference for minimally invasive glaucoma surgery devices over traditional glaucoma surgical equipment. The former devices are safer and more effective than traditional devices. Furthermore, market participants' increased attention to developing stents specifically for minimally invasive glaucoma procedures that can reduce intraocular pressure (IOP) significantly fuels market growth.

Increasing adoption of minimally invasive surgeries over open surgeries will drive the market growth

The minimally invasive glaucoma surgery market is likely to expand due to an increase in the number of cataract and glaucoma procedures. Because of their high procedural volume, these devices are widely employed in surgeries. Furthermore, product approvals for glaucoma surgery instruments are projected to drive segment growth. Glaukos Corporation got FDA approval for the iStent, a minimally invasive glaucoma surgical drainage device used in cataract procedures. Furthermore, another business, Ivantis, gained permission for the Hydrus Microstent (MIGS device) I 2018. These gadgets are effective in glaucoma procedures, accelerating the segment's growth.

The rise in the geriatric population, combined with an increase in the prevalence of glaucoma worldwide, a surge in demand for combined glaucoma and cataract procedures, and an increase in the focus of key manufacturers on the development of MIGS stents, are driving market expansion. Furthermore, AbbVie bought Allergan plc in 2019 for eye care products such as Xen, durysta, ozurdex, and refresh/optive. With these significant improvements, regional players aim for a foothold in the minimally invasive glaucoma surgery device market. As a result, increased usage of minimally invasive glaucoma surgery devices drives market growth.These factors are likely to boost the minimally invasive glaucoma surgery devices market.

Lack of solutions for difficult anatomies is likely to hamper the market growth

However, reimbursement constraints for MIGS devices and a scarcity of experienced specialists impede market expansion.

COVID-19 Impact Analysis

The COVID-19 pandemic is an unusual worldwide public health concern expected to harm the market for minimally invasive glaucoma surgery (MIGS) equipment. For glaucoma surgery, glaucoma specialists favor the trabeculectomy operation. In minimally invasive glaucoma surgery (MIGS) before the COVID-19 epidemic, the iStent inject was the most often done MIGS procedure, followed by XEN and Preserflo. Although trabeculectomy is still the most regularly done established glaucoma surgery, it is being performed less during the COVID-19 pandemic due to a reduction in the number of postoperative visits and procedures required.

Segment Analysis

The trabecular meshwork segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The trabecular meshwork segment is expected to grow significantly during the forecast period due to ineffective drug delivery in glaucoma medication, which has prompted the transition of glaucoma treatment from medication to minimally invasive glaucoma surgery (MIGS) devices, thereby augmenting the market growth. Furthermore, market growth is fueled by introducing new products into the market. For example, On April 2017, Alcon announced the European introduction of the CyPass® Micro-Stent, a micro-invasive glaucoma surgical device designed to reduce intraocular pressure (IOP) in patients with primary open-angle glaucoma. As a result, various market players' number of regulatory authority approvals for products is boosting the market growth.

Geographical Analysis

North America region holds the largest market share of the global minimally invasive glaucoma surgery devices market

North America is likely to hold a substantial market position in the global glaucoma surgery devices market because of the increasing prevalence of glaucoma, expanding elderly population, increased awareness, favorable reimbursement policies, and several key competitors. According to a Glaucoma Research Foundation report published in 2018, an estimated 3 million people have glaucoma, which is expected to rise in the following years. Furthermore, the expanding senior population in the United States increases the risk of glaucoma. Furthermore, rising healthcare expenditures and well-established healthcare infrastructure are propelling the total regional market to new heights.

In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships within key market players will strengthen their product portfolio in the studied market which will drive the market. Also, several product launches in the market will lead to lucrative growth of the market. For instance, in June 2019, Micro Surgical Technology (MST) has released the MST 19-gauge Ahmed Micro-Stent Cutter in partnership with glaucoma and cataract specialist Ike Ahmed, MD. Furthermore, advancements in various surgical devices from established key players, in the United States, are likely to drive the market growth in North America.

Competitive Landscape

The minimally invasive glaucoma surgery devices market is a highly competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Glaukos Corporation, Ivantis Inc, Lumenis Ltd, Novartis, Ellex Medical Lasers, BVI, ASICO, Alco, Katalystsurgical, IOPtima, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the minimally invasive glaucoma surgery devices market globally. For instance, In November 2019, Glaukos Corporation announced the acquisition of Avedro, Inc., a company that likewise develops products for corneal health. This acquisition has resulted in a broadening of the product line. This increased the company's revenue.

Ivantis

Overview:

Ivantis is working on a new glaucoma treatment that incorporates eye drops, laser therapy, and surgery.

Product Portfolio:

Hydrus Microstent: A doctor uses small incisions and modern equipment to place the very flexible Hydrus Microstent, roughly an eyelash size. This less invasive approach to glaucoma surgery results in fewer problems and faster healing times than traditional glaucoma surgery.

Why Purchase the Report?

Visualize the composition of the global minimally invasive glaucoma surgery devices market segmentation by product, type, surgery type, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global minimally invasive glaucoma surgery devices market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global minimally invasive glaucoma surgery devices market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global minimally invasive glaucoma surgery devices market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 180-200 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Minimally Invasive Glaucoma Surgery Devices Market- By Product

Minimally Invasive Glaucoma Surgery Stents

Minimally Invasive Glaucoma Surgery Shunts

Others (Trabectome/Micro-implants/Micro-catheters)

Global Minimally Invasive Glaucoma Surgery Devices Market- By Types

Trabecular

Suprachoroidal

Subconjunctival

Global Minimally Invasive Glaucoma Surgery Devices Market- By Surgery Type

Glaucoma in conjunction with cataract

Stand Alone Glaucoma

Global Minimally Invasive Glaucoma Surgery Devices Market- By End User

Ambulatory Surgical Centers

Ophthalmology Clinics

Eye Hospitals

Others

Global Minimally Invasive Glaucoma Surgery Devices Market- By Region

North America

Europe

Asia-Pacific

Middle East & Africa

South America

Table of Contents

1. Global Minimally Invasive Glaucoma Surgery Devices Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Minimally Invasive Glaucoma Surgery Devices Market-Market Definition and Overview

3. Global Minimally Invasive Glaucoma Surgery Devices Market- Executive Summary

  • 3.1. Market Snippet By Product
  • 3.2. Market snippet By Types
  • 3.3. Market snippet By Surgery Type
  • 3.4. Market Snippet By End User
  • 3.5. Market Snippet by Region

4. Global Minimally Invasive Glaucoma Surgery Devices Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing adoption of minimally invasive surgeries over open surgeries
      • 4.1.1.2. Rising Prevalence of Glaucoma Diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. Alternative treatment methods availability.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Minimally Invasive Glaucoma Surgery Devices Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. Global Minimally Invasive Glaucoma Surgery Devices Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Minimally Invasive Glaucoma Surgery Devices Market- By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
    • 7.1.2. Market Attractiveness Index, By Product Segment
  • 7.2. Minimally Invasive Glaucoma Surgery Stents*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Minimally Invasive Glaucoma Surgery Shunts
  • 7.4. Others

8. Global Minimally Invasive Glaucoma Surgery Devices Market- By Types

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Types
    • 8.1.2. Market Attractiveness Index, By Types
  • 8.2. Trabecular*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Suprachoroidal
  • 8.4. Subconjunctival

9. Global Minimally Invasive Glaucoma Surgery Devices Market- By Surgery Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 9.1.2. Market Attractiveness Index, By Surgery Type
  • 9.2. Glaucoma in conjunction with cataract*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Stand-Alone Glaucoma

10. Global Minimally Invasive Glaucoma Surgery Devices Market- By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Eye Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Ophthalmology Clinics
  • 10.5. Others

11. Global Minimally Invasive Glaucoma Surgery Devices Market- By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Types
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Types
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Types
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surgery Type
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Global Minimally Invasive Glaucoma Surgery Devices Market- Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Global Minimally Invasive Glaucoma Surgery Devices Market- Company Profiles

  • 13.1. Ivantis Inc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Glaukos Corporation
  • 13.3. Lumenis Ltd
  • 13.4. Novartis
  • 13.5. Ellex Medical Lasers
  • 13.6. BVI
  • 13.7. ASICO
  • 13.8. Allcon
  • 13.9. Katalystsurgical
  • 13.10. IOPtima

LIST NOT EXHAUSTIVE

14. Global Minimally Invasive Glaucoma Surgery Devices Market- DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us